Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Hydroxymethylation in Smoking-Associated Cancers. | Int J Mol Sci | 2022 | 35269796 | PubTator, text mining | PubMed |
| Diet and Male Fertility: The Impact of Nutrients and Antioxidants on Sperm Energetic Metabolism. | Int J Mol Sci | 2022 | 35269682 | PubTator, text mining | PubMed |
| Role of Mitochondrial Stress Response in Cancer Progression. | Cells | 2022 | 35269393 | PubTator, text mining | PubMed |
| Inhibition of Heme Export and/or Heme Synthesis Potentiates Metformin Anti-Proliferative Effect on Cancer Cell Lines. | Cancers (Basel) | 2022 | 35267538 | PubTator, text mining | PubMed |
| The evolution and competitive strategies of Akkermansia muciniphila in gut. | Gut Microbes | 2022 | 35263215 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| Development of Metabolic Synthetic Lethality and Its Implications for Thyroid Cancer. | Endocrinol Metab (Seoul) | 2022 | 35255601 | PubTator, text mining | PubMed |
| Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression. | Autophagy | 2022 | 35253629 | PubTator, text mining | PubMed |
| Rare variant in the fumarate hydratase gene found in patients with clinical features of hereditary leiomyomatosis and renal cell cancer (HLRCC): A case series. | Clin Case Rep | 2022 | 35251648 | PubTator, text mining | PubMed |
| Role of magnetic resonance-high intensity focused ultrasound (MR-HIFU) in uterine fibroids management: an updated systematic review and meta-analysis. | Wideochir Inne Tech Maloinwazyjne | 2022 | 35251392 | PubTator, text mining | PubMed |
| Response to the Letter to the Editor Entitled "Do We Have Sufficient Evidence to Define Prognosis for 'Low-grade' Fumarate Hydratase-deficient Renal Cell Carcinoma?" | Adv Anat Pathol | 2022 | 35249991 | PubTator, text mining | PubMed |
| Elevated nuclear localization of glycolytic enzyme TPI1 promotes lung adenocarcinoma and enhances chemoresistance. | Cell Death Dis | 2022 | 35246510 | PubTator, text mining | PubMed |
| Renal Cell Carcinoma With Combined Loss of Fumarate Hydratase and SMARCB1/INI-1. | Mayo Clin Proc | 2022 | 35246295 | PubTator, text mining | PubMed |
| Network Pharmacology Study and Experimental Validation of Yiqi Huayu Decoction Inducing Ferroptosis in Gastric Cancer. | Front Oncol | 2022 | 35237519 | PubTator, text mining | PubMed |
| Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma. | Mol Cell | 2022 | 35216667 | PubTator, text mining | PubMed |
| Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways. | Int J Mol Sci | 2022 | 35216362 | PubTator, text mining | PubMed |
| Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival. | Sci Adv | 2022 | 35213227 | PubTator, text mining | PubMed |
| The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway. | Front Med (Lausanne) | 2022 | 35211489 | PubTator, text mining | PubMed |
| Metabolomics and the Multi-Omics View of Cancer. | Metabolites | 2022 | 35208228 | PubTator, text mining | PubMed |
| The Role of the Metabolome and Non-Coding RNA on Pheochromocytomas and Paragangliomas: An Update. | Metabolites | 2022 | 35208206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=41